PLoS ONE · 2013 · 16 citations · 20 references
MedicineNeurologyPhysiologyAutoimmunityImmunopathologyNeuromuscular DisordersExtraocular Muscle AnatomyExtraocular MusclesMuscle TissueMuscle WeaknessMyasthenia GravisNeuromuscular JunctionExtraocular Muscle HistologyExtraocular Muscle InjectionNeuromuscular Junction PathologyNeuromuscular Junction PhysiologyNeuromuscular Junction TransmissionOcular Myasthenia Gravis
BACKGROUND: The pathogenesis of extraocular muscle (EOM) weakness in myasthenia gravis might involve a mechanism specific to the EOM. The aim of this study was to investigate characteristics of the EOM related to its susceptibility to myasthenia gravis. METHODS: Female F344 rats and female Sprague-Dawley rats were assigned to experimental and control groups. The experimental group received injection with Ringer solution containing monoclonal antibody against the acetylcholine receptor (AChR), mAb35 (0.25 mg/kg), to induce experimental autoimmune myasthenia gravis, and the control group received injection with Ringer solution alone. Three muscles were analyzed: EOM, diaphragm, and tibialis anterior. Tissues were examined by light microscopy, fluorescence histochemistry, and transmission electron microscopy. Western blot analysis was used to assess marker expression and ELISA analysis was used to quantify creatine kinase levels. Microarray assay was conducted to detect differentially expressed genes. RESULTS: In the experimental group, the EOM showed a simpler neuromuscular junction (NMJ) structure compared to the other muscles; the NMJ had fewer synaptic folds, showed a lesser amount of AChR, and the endplate was wider compared to the other muscles. Results of microarray assay showed differential expression of 54 genes in the EOM between the experimental and control groups. CONCLUSION: Various EOM characteristics appear to be related to the increased susceptibility of the EOM and the mechanism of EOM weakness in myasthenia gravis.
20
Myasthenia gravis and myasthenic syndromes.
Harry Oosterhuis, J. B. M. Kuks · PubMed · 1992 · 251 citations
Life Sciences, Immunology, Neurology +17
Myasthenia gravis and myasthenic syndromes
Andrew G. Engel · Annals of Neurology · 1984 · 240 citations
Life Sciences, Immunology, Neurology +17
Maria Isabel Leite, Margaret T. Jones, Philipp Ströbel et al. · American Journal Of Pathology · 2007 · 126 citations · Full text